Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$34.5 - $42.19 $22,080 - $27,001
-640 Reduced 9.25%
6,281 $264,000
Q1 2023

May 12, 2023

BUY
$33.32 - $40.98 $230,607 - $283,622
6,921 New
6,921 $246,000
Q2 2022

Aug 10, 2022

SELL
$63.06 - $84.75 $87,590 - $117,717
-1,389 Reduced 30.74%
3,130 $224,000
Q1 2022

May 16, 2022

BUY
$74.15 - $99.36 $111,966 - $150,033
1,510 Added 50.18%
4,519 $366,000
Q4 2021

Feb 14, 2022

BUY
$86.01 - $102.89 $52,466 - $62,762
610 Added 25.43%
3,009 $309,000
Q3 2021

Nov 15, 2021

SELL
$84.7 - $96.31 $9,994 - $11,364
-118 Reduced 4.69%
2,399 $210,000
Q2 2021

Aug 10, 2021

BUY
$76.44 - $89.57 $192,399 - $225,447
2,517 New
2,517 $225,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.